Quick facts
- A blood culture bottle is a culture medium device: it contains the liquid or solid biological material that supports microbial growth from a blood specimen.
- United States: 21 CFR 866.2300 names the multipurpose culture medium and classifies it Class I (general controls), exempt from premarket notification subject to § 866.9.
- The exemption stops at automation. 21 CFR 866.2560 exempts the microbial growth monitor — "with the exception of automated blood culturing system devices that are used in testing for bacteria, fungi, and other microorganisms in blood and other normally sterile body fluids".
- The bench method is a published standard, not a habit. CLSI document M47, Principles and Procedures for Blood Cultures is the reference laboratories work to for collection and processing.
- Canada has no matching container entry; the bottle is a licensed device and the specimen travels under provincial acceptance criteria, where Public Health Ontario requires packaging that meets federal dangerous goods requirements and no leakage.
- Volume and the number of sets decide the yield. The bottle is the consumable, but the collection protocol is what makes the result useful.
A blood culture is one of the few laboratory investigations where the sample itself is the limiting factor: the bottle holds what the collector puts in it, and no downstream method recovers organisms that were never drawn. That is why the regulation of the bottle and the standard covering the collection are read together.
This article sets out what a blood culture bottle is, how each country regulates the bottle and the instrument that reads it, why automation changes the filing position, what the collection standard requires, and which consumables a blood culture pathway consumes.
What is a blood culture bottle?
Two components sit in one consumable, and separating them explains the regulation.
The medium. A bottle contains a growth medium designed to support a range of organisms. The US entry describes a multipurpose culture medium as a device that "consists primarily of liquid or solid biological materials intended for medical purposes for the cultivation and identification of several types of pathogenic microorganisms without the need of additional nutritional supplements".
The atmosphere and the additive. Aerobic and anaerobic bottles differ in the headspace gas and in the anticoagulant or resin content, which is why a set is normally drawn as a pair rather than as a single bottle.
Around those two sit the accessories that make the pathway work: the collection adaptor or hub, the antiseptic for skin preparation, and the label that carries the patient identifier and the collection time. Each of those is a separate purchase decision with its own specification.
How does the United States regulate the bottle and the instrument?
The bottle and the machine that reads it sit in different positions, and the difference is written into the exemptions.
21 CFR 866.2300 covers the multipurpose culture medium as Class I (general controls), exempt from premarket notification procedures in subpart E of part 807, subject to the limitations of § 866.9. The exemption is therefore conditional on the device staying inside the characteristics of its generic type.
21 CFR 866.2560 covers the microbial growth monitor, which measures bacterial concentration in a liquid medium "by measuring changes in light scattering properties, optical density, electrical impedance, or by making direct bacterial counts". Its classification is Class I, and then comes the sentence that matters: "With the exception of automated blood culturing system devices that are used in testing for bacteria, fungi, and other microorganisms in blood and other normally sterile body fluids, this device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter."
Three readings follow for a buyer or a specifier.
- The consumable and the instrument are separate regulatory objects. A Class I bottle with a conditional exemption does not carry the instrument with it.
- Automation removes the exemption. An automated blood culturing system used on blood and other normally sterile body fluids is carved out of the exemption, so the premarket route applies to it.
- The carve-out is about the specimen, not the brand. The exception is written around blood and normally sterile body fluids, which is precisely the specimen type a blood culture bottle exists to serve.
Neighbouring entries show how granular the part is: 21 CFR 866.2170 covers the automated colony counter, 21 CFR 866.2180 the manual colony counter, and 21 CFR 866.2390 the transport culture medium — three lines for three different jobs in the same bench workflow.
How does Canada handle the same bottle?
Canada does not name a bottle entry. The device is classified under the rules and reaches the market through the licence route, and the specimen end of the process is governed by provincial criteria.
Two layers matter.
The device layer. Culture media and the instruments that incubate and read them are devices under the Medical Devices Regulations, SOR/98-282. A supplier importing them into Canada holds an establishment licence; CliniEco Medical holds Health Canada MDEL #35334 on that basis.
The laboratory layer. In Ontario, laboratories and specimen collection centres operate under the Laboratory and Specimen Collection Centre Licensing Act, R.S.O. 1990, c. L.1, and medical laboratories commonly work to ISO 15189:2022. Specimen acceptance is published: the Public Health Ontario criteria for acceptance of specimens require, among other things, that packaging meets the minimum federal dangerous goods packaging requirements and that the specimen is not leaking.
| Item | Canada | United States |
|---|---|---|
| Named entry for a culture medium | None; classified by rule | 21 CFR 866.2300, multipurpose culture medium |
| Named entry for the reading instrument | None; classified by rule | 21 CFR 866.2560, microbial growth monitor |
| Class of the medium | Derived from the rules | Class I (general controls) |
| Premarket position of the medium | Device licence where the derived class requires it | Exempt from premarket notification, subject to § 866.9 |
| Premarket position of an automated blood culture system | Device licence where the derived class requires it | Excepted from the exemption for devices used on blood and normally sterile body fluids |
| Specimen acceptance | Published provincial criteria, including packaging and leak checks | Laboratory policies required by 42 CFR 493.1242 |
| Collection standard | CLSI M47, used as the bench reference | CLSI M47, used as the bench reference |
What does the collection standard cover?
CLSI M47, Principles and Procedures for Blood Cultures, is the reference that most North American laboratories cite for the collection and processing of blood cultures. Its subject is the method rather than the consumable, and four items carry most of the operational weight.
Skin antisepsis. Contamination is the failure mode that costs most, because a contaminated culture produces a result that has to be interpreted rather than acted on. The preparation agent, the contact time and the technique are procedural steps, not preferences.
Volume. The single largest determinant of yield is how much blood reaches the bottle. A bottle that is underfilled does not fail visibly; it simply recovers fewer organisms.
Number of sets. Drawing one set instead of the protocol's number reduces the chance of detecting a bacteraemia, and the protocol states the number for a reason.
Timing and documentation. The collection time, the site and the number of sets belong on the requisition, because the interpretation of a positive culture depends on all three.
A laboratory working under its own policies in the United States has to write down the transport and handling side. 42 CFR 493.1242 requires written policies and procedures for patient preparation, specimen collection, labelling including patient identity and specimen source, storage and preservation, conditions of transportation, processing, acceptability and rejection, and referral — and a documented date and time of receipt.
| Item | Canada | United States |
|---|---|---|
| Bench reference for collection | CLSI M47 | CLSI M47 |
| Antisepsis and technique | Laboratory procedure, based on the published standard | Laboratory procedure, based on the published standard |
| Volume per bottle | Protocol-defined, decided by the laboratory | Protocol-defined, decided by the laboratory |
| Number of sets | Protocol-defined | Protocol-defined |
| Transport packaging | Federal dangerous goods packaging requirements, plus published acceptance criteria | Conditions of transportation set out in laboratory policies |
| Documentation at receipt | Provincial accessioning practice | Date and time of receipt, recorded |
Why does the automation exception matter commercially?
Because it changes which organisation has to file, and therefore which products can be sold into a market without a premarket submission.
A non-automated growth monitor sits inside an exemption and a plain culture medium sits inside an exemption. The automated blood culture system used on blood is carved out of the exemption, which means the instrument's route to market is a premarket submission rather than a declaration of exemption. A laboratory specifying an automated system is therefore buying a device whose regulatory history exists, and that history is worth asking for: the submission number is a public record of the intended use the device was cleared for.
The same logic applies to consumables. A bottle is bought for a specific instrument, and the instrument's cleared intended use is what defines the specimen types and conditions under which the bottle may be used.
Which consumables does a blood culture pathway consume?
- The bottles and their accessories. Aerobic and anaerobic bottles ordered as a set, together with the collection adaptor and the label stock that carries the patient identifier and the collection time.
- Specimen transport. Where a bottle or a subculture leaves the site, it travels inside packaging built for specimens: UN3373 specimen transport bags or 3-wall leak-resistant transport bags.
- Hand contact and site preparation. Nitrile examination gloves are consumed at every draw, and sterile gauze sponges are stocked for site preparation and for what follows the draw.
- Sharps and waste. Sharps containers take the needle, and biohazard waste bags take the rest of the collection waste.
Sources
- 21 CFR 866.2300, multipurpose culture medium
- 21 CFR 866.2560, microbial growth monitor
- 21 CFR 866.2170, automated colony counter
- 21 CFR 866.2180, manual colony counter
- 21 CFR 866.2390, transport culture medium
- 21 CFR part 866, immunology and microbiology devices
- CLSI M47, principles and procedures for blood cultures
- CLSI microbiology standards
- CLSI standards catalogue
- 42 CFR 493.1242, specimen submission, handling and referral
- 42 CFR 493.5, categories of tests by complexity
- Medical Devices Regulations, SOR/98-282
- Ontario, Laboratory and Specimen Collection Centre Licensing Act
- Public Health Ontario, criteria for acceptance of specimens
- Public Health Ontario, anaerobic bacterial cultures
- Public Health Ontario, blood-borne infections
- Public Health Ontario, test information index
- ISO 15189:2022, medical laboratory quality and competence
- ISO 6710:2017, single-use blood specimen containers
- CCOHS, needlestick injuries
Ordering for a clinic, laboratory or care home? Wholesale and multi-site ordering covers account setup and case pricing, and the B2B wholesale collection lists the lines stocked for institutional buyers. Clinics that also run an in-house sterilizer can start with the biological indicator 5-pack trial.
Related reading
- 24-hour urine collection in Canada vs the US: which container rules apply
- EDTA tubes in Canada vs the US: which draw rules apply
- Serum separator tubes in Canada vs the US: which draw rules apply
- Butterfly needles in Canada vs the US: which gauge rules apply
- At-home COVID-19 and flu test kits in Canada vs the US: which rules apply
Frequently Asked Questions
Is a blood culture bottle a Class I device in the United States?
The culture medium inside it is. A multipurpose culture medium is Class I under 21 CFR 866.2300, with general controls and an exemption from premarket notification subject to the limitations in § 866.9. The bottle as a finished consumable is bought against that entry together with the instrument it is designed for.
Why is an automated blood culture system treated differently?
Because 21 CFR 866.2560 carves it out. The exemption for the microbial growth monitor applies "with the exception of automated blood culturing system devices that are used in testing for bacteria, fungi, and other microorganisms in blood and other normally sterile body fluids". An automated system used on blood therefore takes the premarket route.
What standard covers blood culture collection?
CLSI M47, Principles and Procedures for Blood Cultures, is the reference document laboratories work to for the collection, processing and interpretation of blood cultures. The specimen-handling side is also written into laboratory policy, which in the United States means the written policies required by 42 CFR 493.1242.
What matters more, the bottle or the collection?
The collection. Underfilling a bottle or drawing fewer sets than the protocol requires reduces the chance of recovering an organism, and neither fault is visible in the bottle afterwards. The bottle's job is to support growth when the specimen has been taken according to the protocol.
How does Canada regulate culture media?
Through the rules in the Medical Devices Regulations rather than a named entry, with the licence route following the derived class. A distributor importing culture media into Canada holds an establishment licence, and the specimen end of the pathway is governed by provincial acceptance criteria such as those published by Public Health Ontario.
What should be on the requisition?
The collection time, the collection sites and the number of sets, together with the patient identifier and the specimen source. Those four items are what the laboratory uses to interpret a positive culture, and 42 CFR 493.1242 requires patient identity and specimen source as part of labelling.
CliniEco Medical supplies laboratory and specimen handling consumables described in this article. Health Canada MDEL #35334. This article is written for clinic, laboratory and procurement professionals and is not clinical guidance; collection protocols and culture interpretation belong to the treating laboratory.
0 commentaire